About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 405 blog entries.

Clinical validation of SARC-F by proxy as a practical tool to evaluate sarcopenia in dependent older adults

2023-09-27T14:23:44+02:00

Serdar Ozkok Meryem Merve Oren Caglar Ozer Aydin Humeyra Ozalp Cihan Kilic Yasagul Koc Hafize Dogan Onder Yuksel Eryigit Mehmet Akif Karan Gulistan Bahat Published: September 21, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101630

Clinical validation of SARC-F by proxy as a practical tool to evaluate sarcopenia in dependent older adults2023-09-27T14:23:44+02:00

Rethinking care management for older adults with cancer: Proposals from the “PRIORITES AGE CANCER” French group

2023-09-11T14:00:37+02:00

Angéline Galvin Nicolas Bertrand Rabia Boulahssass Laure De Decker Etienne Dorval Béatrice Clairaz Monique Castaignède Loic Mourey Capucine Baldini Eric Bauvin Béatrice Jacques Isabelle Mallon Isabelle Durand-Zaleski Olivier Guérin Sadek Krouri Pierre Soubeyran DOI:https://doi.org/10.1016/j.jgo.2023.101608

Rethinking care management for older adults with cancer: Proposals from the “PRIORITES AGE CANCER” French group2023-09-11T14:00:37+02:00

Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative

2023-09-11T13:58:25+02:00

Angéline Galvin Pierre Soubeyran Etienne Brain Kwok-Leung Cheung Marije E. Hamaker Ravindran Kanesvaran Murielle Mauer Supriya Mohile Isacco Montroni Martine Puts Siri Rostoft Hans Wildiers Simone Mathoulin-Pélissier Carine Bellera DOI:https://doi.org/10.1016/j.jgo.2023.101611

Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative2023-09-11T13:58:25+02:00

Medication assessment in older adults with cancer – Current practices in clinical pharmacy

2023-08-17T18:13:44+02:00

INTRODUCTION Clinical pharmacists, especially those working in oncology settings, play a pivotal role in medication management for older adults with cancer. Clinical pharmacists conduct structured medication assessments, which can include adverse effect assessment, interaction assessments, adherence monitoring, medication reconciliation, and in certain jurisdictions, prescribing and deprescribing. Pharmacists offer the Geriatric Oncology MDT suggestions to enhance medication safety, taking multiple factors into consideration, including the patient's age, comorbidities, and factors influencing drug metabolism and elimination. The SIOG Nursing and Allied Health Interest Group have recently published a perspective paper highlighting the role of clinical pharmacists in geriatric oncology[1]. We sat down with the lead author, Darren Walsh, pharmacist in University Hospital Waterford (Ireland) to discuss the growing recognition of clinical pharmacy as a key component of a wider multidisciplinary team within Geriatric Oncology. Roles and Responsibilities of Clinical Pharmacists Could you discuss the roles and responsibilities of clinical pharmacists in a [...]

Medication assessment in older adults with cancer – Current practices in clinical pharmacy2023-08-17T18:13:44+02:00

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study

2023-05-31T11:51:11+02:00

Fabio P. Mansani Ruffo Freitas-Junior Published: May 22, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101526

Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study2023-05-31T11:51:11+02:00

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08–02 study

2023-05-31T11:49:13+02:00

Sébastien Gendarme Sonia Zebachi Romain Corre Laurent Greillier Grégoire Justeau Olivier Bylicki Chantal Decroisette Jean-Bernard Auliac Florian Guisier Margaux Geier Charles Ricordel Maxime Frelaut Elena Paillaud Christos Chouaïd Florence Canouï-Poitrine Published: May 19, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101506

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08–02 study2023-05-31T11:49:13+02:00

Medication assessment in older adults with cancer – Current practices in clinical pharmacy

2023-05-31T11:47:23+02:00

Darren J. Walsh Kavita Kantilal Chloé Herledan Ginah Nightingale Vanya Slavova-Boneva Maria-Estela Moreno-Martínez Samantha Penn Joey Chien Kumud Kantilal Published: May 19, 2023 DOI :https://doi.org/10.1016/j.jgo.2023.101531

Medication assessment in older adults with cancer – Current practices in clinical pharmacy2023-05-31T11:47:23+02:00
Go to Top